Left behind: Should minimal residual disease be treated in hairy cell leukemia? Journal Article

  

Authors:	Park, J. H.; Tallman, M. S.
Article Title:	Left behind: Should minimal residual disease be treated in hairy cell leukemia?
Keywords:	immunohistochemistry; treatment duration; note; rituximab; flow cytometry; follow up; minimal residual disease; real time polymerase chain reaction; leukemia relapse; pentostatin; cladribine; leukemia remission; hairy cell leukemia; clinical trial (topic); vemurafenib; human; priority journal
Journal Title:	Leukemia and Lymphoma
Volume:	55
Issue:	5
ISSN:	1042-8194
Publisher:	Taylor & Francis Group
Date Published:	2014-05-01
Start Page:	971
End Page:	972
Language:	English
DOI:	10.3109/10428194.2013.866667
PROVIDER:	scopus
PUBMED:	24512318
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84899709227&partnerID=40&md5=4c52a63bdea75e2393040ce537e1a046
Notes:	Leuk. Lymphoma -- Export Date: 2 June 2014 -- CODEN: LELYE -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/51840